Genomictree Inc. (KOSDAQ: 228760)

Genomictree Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	23,081	45,269	67,572	66,461	56,641	42,900
Short-Term Investments	76,283	47,877	47,033	64,081	46,478	57,406
Cash & Short-Term Investments	99,364	93,146	114,605	130,542	103,119	100,306
Cash Growth	0.27%	-18.72%	-12.21%	26.59%	2.81%	1256.67%
Accounts Receivable	413.22	388.29	1,031	2,267	128.37	40.49
Other Receivables	276.15	286.19	144.11	28.22	148.98	86.63
Receivables	689.37	674.47	1,175	2,295	277.36	127.11
Inventory	427.27	496.53	635.45	284.87	1,231	266.53
Prepaid Expenses	463.44	395.89	424.22	502.98	416.53	651.43
Other Current Assets	454.55	657.95	1,160	702.45	255.99	707.49
Total Current Assets	101,399	95,371	118,000	134,327	105,300	102,058
Property, Plant & Equipment	20,118	17,460	17,866	21,459	10,633	7,535
Long-Term Investments	9,197	14,048	21,136	19,656	969.4	3,066
Other Intangible Assets	1,271	1,336	1,470	1,523	752.73	770.06
Long-Term Deferred Charges	0	20.92	83.67	146.43	209.19	271.94
Other Long-Term Assets	4,912	4,608	4,354	40.12	30.88	24.54
Total Assets	136,896	132,844	162,910	177,151	117,896	113,725
Accounts Payable	96.06	66.79	132.6	87.57	83.8	226.22
Accrued Expenses	1,539	1,433	1,821	441.27	341.7	289.97
Short-Term Debt	1,825	1,690	29,043	-	-	-
Current Portion of Long-Term Debt	0	0	0	-	80	-
Current Portion of Leases	47.42	47.42	52.8	265.79	204.62	-
Current Income Taxes Payable	-	-	1.7	-	-	-
Current Unearned Revenue	-	0.64	9.8	28.6	15	0.17
Other Current Liabilities	1,497	2,044	22,381	1,319	3,364	947.54
Total Current Liabilities	5,005	5,281	53,442	2,142	4,090	1,464
Long-Term Debt	-	-	-	37,271	10,332	1,200
Long-Term Leases	79.19	97.52	84.63	907.61	929.65	-
Long-Term Deferred Tax Liabilities	92.97	92.97	579.61	206.6	206.6	206.6
Other Long-Term Liabilities	28.57	49.94	44.39	18,770	4,735	29.67
Total Liabilities	7,898	7,812	55,353	62,050	22,640	4,904
Common Stock	12,181	12,006	10,513	10,164	9,993	9,993
Additional Paid-In Capital	85,869	79,972	57,050	55,819	118,518	118,518
Retained Earnings	25,499	31,274	39,976	46,434	-32,310	-20,347
Treasury Stock	-4,984	-4,984	-4,984	-	-	-
Comprensive Income & Other	10,058	6,468	4,345	2,296	-945.99	755.29
Total Common Equity	128,623	124,736	106,900	114,713	95,255	108,919
Minority Interest	375.38	295.48	502.28	-	-	-98.86
Shareholders' Equity	128,998	125,032	107,557	115,101	95,255	108,821
Total Liabilities & Equity	136,896	132,844	162,910	177,151	117,896	113,725
Total Debt	1,952	1,835	29,180	38,444	11,546	1,200
Net Cash (Debt)	97,412	91,312	85,425	92,098	91,573	99,106
Net Cash Growth	7.96%	6.89%	-7.24%	0.57%	-7.60%	1426.23%
Net Cash Per Share	4125.56	3444.88	4069.68	4461.03	4581.82	5185.39
Filing Date Shares Outstanding	23.98	23.63	20.65	20.33	19.99	19.99
Total Common Shares Outstanding	23.98	23.63	20.65	20.33	19.99	19.99
Working Capital	96,394	90,090	64,557	132,185	101,211	100,594
Book Value Per Share	5363.30	5278.29	5177.78	5643.25	4766.06	5449.73
Tangible Book Value	127,352	123,400	105,429	113,190	94,503	108,149
Tangible Book Value Per Share	5310.32	5221.76	5106.57	5568.33	4728.39	5411.20
Land	8,354	7,981	7,924	9,612	4,632	1,758
Buildings	6,466	6,167	6,100	8,064	2,295	2,087
Machinery	8,606	6,102	6,016	4,524	4,083	2,528
Construction In Progress	326.11	326.11	133.2	138.2	1.71	2,198

Source: S&P Capital IQ. Standard template. Financial Sources.